Gå til indhold

Forskningsresultater med Re5-teknologien til Parkinson's sygdom

 

 

  • Ca. 15% forbedret bevægehastighed
  • Betydeligt øget niveau af erythropoietin (EPO) cerebrospinalvæsken
  • Funktionel forbedring drevet af øget niveau af dopamin i hjernen samt muligvis EPO-induceret neural reparation og/eller beskyttelse af dopaminerge neuroner
  • Ingen alvorlige bivirkninger eller uønskede hændelser
  • Re5 teknologien er foreløbigt kun til klinisk afprøvning i forhold til Parkinson's Sygdom

 

Forskningsresultaterne præsenteret

 

Forskning i Parkinson's Sygdom med Re5

 

Long-term treatment with transcranial pulsed electromagnetic fields improves movement speed and elevates cerebrospinal erythropoietin in Parkinson’s disease (2021)

The effect of 8 weeks of treatment with transcranial pulsed electromagnetic fields on hand tremor and inter-hand coherence in persons with Parkinson’s disease (2019)

The Hawthorne effect as a pre-placebo expectation in Parkinsons disease patients participating in a randomized placebo-controlled clinical study (2019)

Effects of Long-Term Treatment with T-PEMF on Forearm Muscle Activation and Motor Function in Parkinson’s Disease (2018)

Effect of T-PEMF on functional rate of force development and movement speed in persons with Parkinson’s disease: A randomized clinical trial (2018)

Effects of transcranial pulsed electromagnetic field stimulation on quality of life in Parkinson's disease (2018)

Parkinson’s Disease and Transcranial Pulsed Electromagnetic Fields: A Randomized Clinical Trial (2017)

Effect of pulsed electromagnetic fields in patients with idiopathic Parkinson’s disease: A pilot study (2008)

Tilmeld dig vores nyhedsbrev